Kyowa Kirin will file for rocatinlimab’s US approval, which was once Amgen’s most late-stage pipeline candidate.

The ADHAND trial has demonstrated that tralokinumab significantly improved skin clarity, itch, and pain in adults with moderate-to-severe hand atopic dermatitis. All primary and secondary ...

Food allergies in children are rising globally. Doctors explain why allergies are increasing, early warning signs parents ...

Remibrutinib, a BTK inhibitor, offers a new oral treatment for chronic spontaneous urticaria, providing an alternative to traditional therapies. Experts discuss groundbreaking therapies in dermatology ...

In a survey conducted by Vaseline among 86 users, 99 per cent praised the product for gently soothing their skin’s redness ...

Rocatinlimab, targeting the OX40 pathway, shows significant efficacy in moderate to severe atopic dermatitis, marking a new therapeutic class in disease management. Long-term melanoma data reveal ...

It causes an itchy rash spread through close skin contact and is very hard to get rid of - and doctors often fail to diagnose ...

An article Food Allergy – A Hidden Crisis (Jan 26) in The Star reports that in Malaysia, doctors say food allergies are no ...

Three editors aged between 27 and 49 have put Project E Beauty's LED face mask to the test. Click to find out what they discovered, and if you should invest in ...

You might be damaging your skin without even realizing it. Uncover 10 common daily habits that can lead to breakouts, aging, ...

The disease is uncomfortable, causing an itchy rash ...